Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 138

1.

Soluble guanylate cyclase stimulators increase sensitivity to cisplatin in head and neck squamous cell carcinoma cells.

Tuttle TR, Takiar V, Kumar B, Kumar P, Ben-Jonathan N.

Cancer Lett. 2017 Mar 28;389:33-40. doi: 10.1016/j.canlet.2016.12.020. Epub 2016 Dec 23.

2.

Bisphenols Come in Different Flavors: Is "S" Better Than "A"?

Ben-Jonathan N, Hugo ER.

Endocrinology. 2016 Apr;157(4):1321-3. doi: 10.1210/en.2016-1120. No abstract available.

3.

The cyclic GMP/protein kinase G pathway as a therapeutic target in head and neck squamous cell carcinoma.

Tuttle TR, Mierzwa ML, Wells SI, Fox SR, Ben-Jonathan N.

Cancer Lett. 2016 Jan 28;370(2):279-85. doi: 10.1016/j.canlet.2015.10.024. Epub 2015 Nov 10.

4.

Expression and therapeutic targeting of dopamine receptor-1 (D1R) in breast cancer.

Borcherding DC, Tong W, Hugo ER, Barnard DF, Fox S, LaSance K, Shaughnessy E, Ben-Jonathan N.

Oncogene. 2016 Jun 16;35(24):3103-13. doi: 10.1038/onc.2015.369. Epub 2015 Oct 19.

5.

Knockdown of the Inhibitor of Apoptosis BRUCE Sensitizes Resistant Breast Cancer Cells to Chemotherapeutic Agents.

Garrison JB, Ge C, Che L, Pullum DA, Peng G, Khan S, Ben-Jonathan N, Wang J, Du C.

J Cancer Sci Ther. 2015 Apr;7(4):121-126.

6.

Prolactin (PRL) in adipose tissue: regulation and functions.

Ben-Jonathan N, Hugo E.

Adv Exp Med Biol. 2015;846:1-35. doi: 10.1007/978-3-319-12114-7_1. Review.

PMID:
25472532
7.

Minireview: Extrapituitary prolactin: an update on the distribution, regulation, and functions.

Marano RJ, Ben-Jonathan N.

Mol Endocrinol. 2014 May;28(5):622-33. doi: 10.1210/me.2013-1349. Epub 2014 Apr 2. Review.

8.

Placental lactogen is expressed but is not translated into protein in breast cancer.

Tuttle TR, Hugo ER, Tong WS, Ben-Jonathan N.

PLoS One. 2014 Jan 24;9(1):e87325. doi: 10.1371/journal.pone.0087325. eCollection 2014.

9.

Adipogenic effect of calcium sensing receptor activation.

Villarroel P, Reyes M, Fuentes C, Segovia MP, Tobar N, Villalobos E, Martínez J, Hugo E, Ben-Jonathan N, Cifuentes M.

Mol Cell Biochem. 2013 Dec;384(1-2):139-45. doi: 10.1007/s11010-013-1791-7. Epub 2013 Sep 5.

PMID:
24005534
10.

Phosphorylation at tyrosine 114 of Proliferating Cell Nuclear Antigen (PCNA) is required for adipogenesis in response to high fat diet.

Lo YH, Ho PC, Chen MS, Hugo E, Ben-Jonathan N, Wang SC.

Biochem Biophys Res Commun. 2013 Jan 4;430(1):43-8. doi: 10.1016/j.bbrc.2012.11.047. Epub 2012 Nov 28.

11.

Calcium sensing receptor activation elevates proinflammatory factor expression in human adipose cells and adipose tissue.

Cifuentes M, Fuentes C, Tobar N, Acevedo I, Villalobos E, Hugo E, Ben-Jonathan N, Reyes M.

Mol Cell Endocrinol. 2012 Sep 25;361(1-2):24-30. doi: 10.1016/j.mce.2012.03.006. Epub 2012 Mar 16.

12.

Dopamine receptors in human adipocytes: expression and functions.

Borcherding DC, Hugo ER, Idelman G, De Silva A, Richtand NW, Loftus J, Ben-Jonathan N.

PLoS One. 2011;6(9):e25537. doi: 10.1371/journal.pone.0025537. Epub 2011 Sep 26.

13.

Lactogens and estrogens in breast cancer chemoresistance.

Idelman G, Jacobson EM, Tuttle TR, Ben-Jonathan N.

Expert Rev Endocrinol Metab. 2011 May;6(3):411-422.

14.

Prolactin in breast and prostate cancer: molecular and genetic perspectives.

Jacobson EM, Hugo ER, Borcherding DC, Ben-Jonathan N.

Discov Med. 2011 Apr;11(59):315-24. Review.

15.

Unexploited therapies in breast and prostate cancer: blockade of the prolactin receptor.

Jacobson EM, Hugo ER, Tuttle TR, Papoian R, Ben-Jonathan N.

Trends Endocrinol Metab. 2010 Nov;21(11):691-8. doi: 10.1016/j.tem.2010.08.004. Epub 2010 Sep 16. Review.

16.

Obesity-associated proinflammatory cytokines increase calcium sensing receptor (CaSR) protein expression in primary human adipocytes and LS14 human adipose cell line.

Cifuentes M, Fuentes C, Mattar P, Tobar N, Hugo E, Ben-Jonathan N, Rojas C, Martínez J.

Arch Biochem Biophys. 2010 Aug 15;500(2):151-6. doi: 10.1016/j.abb.2010.05.033. Epub 2010 Jun 4.

PMID:
20595056
17.

Selective estrogen receptor down-regulator and selective estrogen receptor modulators differentially regulate lactotroph proliferation.

Kansra S, Chen S, Bangaru ML, Sneade L, Dunckley JA, Ben-Jonathan N.

PLoS One. 2010 Apr 19;5(4):e10060. doi: 10.1371/journal.pone.0010060.

18.

Novel roles of prolactin and estrogens in breast cancer: resistance to chemotherapy.

LaPensee EW, Ben-Jonathan N.

Endocr Relat Cancer. 2010 Feb 25;17(2):R91-107. doi: 10.1677/ERC-09-0253. Print 2010 Jun. Review.

PMID:
20071456
19.

Bisphenol A and estradiol are equipotent in antagonizing cisplatin-induced cytotoxicity in breast cancer cells.

LaPensee EW, LaPensee CR, Fox S, Schwemberger S, Afton S, Ben-Jonathan N.

Cancer Lett. 2010 Apr 28;290(2):167-73. doi: 10.1016/j.canlet.2009.09.005. Epub 2009 Sep 30.

20.

Epidermal growth factor receptor cross-talks with ligand-occupied estrogen receptor-alpha to modulate both lactotroph proliferation and prolactin gene expression.

Chen S, Bangaru ML, Sneade L, Dunckley JA, Ben-Jonathan N, Kansra S.

Am J Physiol Endocrinol Metab. 2009 Aug;297(2):E331-9. doi: 10.1152/ajpendo.00133.2009. Epub 2009 May 26.

Supplemental Content

Loading ...
Support Center